Researchers at the University of Pittsburgh are seeking participants with and without a diagnosis of multiple sclerosis for a survey study to help better understand the risk and impact of COVID-19. Participation in this research study involves completing multiple surveys online over the course of one year.
Multiple sclerosis (MS) is a disease that gradually destroys the protective covering of nerve cells in the brain and spinal cord, which can lead to problems with muscle control and strength, vision, balance, feeling, and thinking. People who have MS are also at an increased risk for infections, but there is little information about how COVID-19 affects people with the condition.
The purpose of this survey study is to better understand how COVID-19 affects people with MS and compare them to people who do not have a diagnosis of MS. Researchers hope their findings will lead to better guidance for people with MS or related neuroinflammatory conditions.
COULD THIS STUDY BE RIGHT FOR YOU?
- Ages 18 and up
- Participants may or may not have a diagnosis of multiple sclerosis
- Participants may or may not have a past or current COVID-19 diagnosis
- Not participating in the PROMOTE Study
WHAT PARTICIPANTS CAN EXPECT
Participation takes place entirely online. Participants will be asked to complete a series of online questionnaires over 12 months. Questionnaires will be sent every two weeks for the first two months, and once per month afterwards. Each questionnaire will take about 10-30 minutes to complete.
IRB: STUDY20040160- The COVID-19 and Multiple Sclerosis Survey Study
MEET THE RESEARCHER
Zongqi Xia, MD, PhD, is a neurologist and scientist, a Principal Investigator, and an Assistant Professor of Neurology, Biomedical Informatics and Bioengineering at the University of Pittsburgh. Dr. Xia’s research focuses on bringing precision medicine to people with multiple sclerosis and related disorders of neuroinflammation and neurodegeneration.